| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |